Ludwig Cancer Research is a global community of leading scientists pursuing innovative ways to prevent and control cancer. From basic research to clinical trials, in individual laboratories or as part of international teams, our researchers are tackling the hardest questions, spotting the connections and the possibilities. At Ludwig, we test our work against the one measure that matters — improving human health. Ludwig Cancer Research is a global community of leading scientists pursuing innovative ways to prevent and control cancer. From basic research to clinical trials, in individual laboratories or as part of international teams, our researchers are tackling the hardest questions, spotting the connections and the possibilities. At Ludwig, we test our work against the one measure that matters — improving human health.

  I am a scientist with expertise in developmental neuroscience and cell signaling. My research is focused on understanding how the brain's dopamine neurons are developing and how they are maintained in the adult brain. The studies have particular relevance for Parkinson's disease, but the fundamental understanding of how neural stem cells are controlled is also resulting in insights relevant in cancer. I am the director of the Ludwig Institute in Stockholm and a full professor in the department of Cell and Molecular Biology at the Karolinska Institute.I am responsible for training PhD students and postdoctorals, as well as teaching medical and doctoral students at the Karolinska Institute. I also serve on the Nobel Committee at the Karolinska Institute. Education PhD, Karolinska Institute, 1991 MSc, Stockholm University, 1986 Achievements Eric K. Fernström, Young Investigator Prize, 1997 Göran Gustafsson Prize in Molecular Biology, 1999 Member of the Nobel Assembly, Karolinska Institute, 2006 Member, Royal Swedish Academy of Sciences, 2008